| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/02/2003 | US20030003489 Nucleotide sequences coding peptides for use in the treatment of tumors |
| 01/02/2003 | US20030003486 Oligonucleotide for use as signaling tool in genetic analysis |
| 01/02/2003 | US20030003485 Detection of nucleotide sequences coding preferential membrane protein; obtain cell sample containing preferential membrane protein, incubate with human leukocyte antigen, monitor secreted proteins |
| 01/02/2003 | US20030003483 Amplifiable probe |
| 01/02/2003 | US20030003482 Diagnosing skin disorders and diabetic injury; obtain sample, incubate with probe detect and determine gene expression concentration of preferential gene, amplified gene expression indicates skin disorder |
| 01/02/2003 | US20030003481 Detection of nucletide sequence polymerase inhibitors; obtain nucleotide sequences, incubate wih inhibitors, detect reduction in enzyme activity, reduction enzyme activity indicates inhibitor |
| 01/02/2003 | US20030003480 Reactive solid support and DNA fragment detection tool |
| 01/02/2003 | US20030003478 Identifying and characterizing genes |
| 01/02/2003 | US20030003477 Nucleotide sequences coding polypeptides for use in the treatment of nervous system, kidney, muscle, allergic and cancer disorders |
| 01/02/2003 | US20030003476 Waste water inspecting agent and waste water inspecting apparatus using the same |
| 01/02/2003 | US20030003472 Detection of genetic aberration in sample; obtain nucleotide sequences, incubate with oligonucleotides, detect aberration in hybridization, presence of aberration indicates variablity in nucleotide sequences |
| 01/02/2003 | US20030003470 Kit for use in the diagnosis of hypertension; obtain sample, determine pattern of alleles, detect preferential gene expression, preferential gene expression indicates hypertension |
| 01/02/2003 | US20030003467 Methods for diagnosing and treating pediatric neoplasms |
| 01/02/2003 | US20030003465 Mass spectrometric detection of polypeptides |
| 01/02/2003 | US20030003464 Detection of preferential particles in sample; obtain sample, incubate with binding agent, detect bound particles |
| 01/02/2003 | US20030003462 Novel human interleukin-like proteins and polynucleotides encoding them |
| 01/02/2003 | US20030003461 Truncation selex method |
| 01/02/2003 | US20030003460 Microparticles for use as luminesencent tool in bioassays |
| 01/02/2003 | US20030003456 Method and system of identifying biologically active molecules |
| 01/02/2003 | US20030003454 Diagnosing cancer in humans; obtain tissue sample, monitor expression of nucleotide sequences maintanance enzymes, amplified concentration of enzyme indicates cancer |
| 01/02/2003 | US20030003448 Method |
| 01/02/2003 | US20030003447 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/02/2003 | US20030003446 Determination of viral concentration in sample; obtain cell sample, incubate with viricide, detect presence of viral protein, determine concentration of viral proteins |
| 01/02/2003 | US20030003444 R9Detection of preferential polypeptide in sample; obtain sample of polypeptide, incubate with bacteriophage, monitor adjustment in activity, adjustment in activity |
| 01/02/2003 | US20030003443 Designation MVP-5180/91, deposited with the European Collection of Animal Cell Cultures under No V 920 92 318 |
| 01/02/2003 | US20030003442 Retrovirus from the HIV group and its use |
| 01/02/2003 | US20030003441 Detection of parasite in sample; obtain sample, incubate with coded microbeads, expose to antibodies, detect and measure preferential particle in sample |
| 01/02/2003 | US20030003440 Immunogenic peptide for use in the detection and prevention of viral diseases |
| 01/02/2003 | US20030003436 Use of mesoscale self-assembly and recognition to effect delivery of sensing reagent for arrayed sensors |
| 01/02/2003 | US20030003223 Reacting surface with a silane, especially a bis(silylalkyl)alkylenediamine; activation with a haloacetic acid; chelators |
| 01/02/2003 | US20030003101 Treatment and diagnosis of prostate cancer |
| 01/02/2003 | US20030003096 Only specifically binds activated factor VII, and not factor VII, and does not bind to an activated factor VII which is complexed with antithrombin III |
| 01/02/2003 | US20030003050 Detecting a difference in an untranslated region of mRNA for a gene in which diversity in untranslated region of mRNA affects sensitivity to a drug, and evaluating sensitivity to a drug based on the detected difference |
| 01/02/2003 | US20030003025 Microvolume liquid dispenser suitable for microarrays and methods related thereto |
| 01/02/2003 | US20030003022 Automatic smear preparing apparatus and automatic sample analysis system having the same |
| 01/02/2003 | US20030003020 Apparatus for preparing microarrays |
| 01/02/2003 | US20030003019 To detect residual hydrocarbon contamination on a surface |
| 01/02/2003 | US20030002387 Magazine for storing test elements |
| 01/02/2003 | US20030001595 Through-log density detector |
| 01/02/2003 | US20030000836 Subjecting a sample to membrane-based electrophoresis to separate at least some prions present in the sample; detecting the presence of separated prions |
| 01/02/2003 | US20030000834 Method for analyzing a biological sample |
| 01/02/2003 | US20030000670 Method for determining a characteristic value for the binding force potential of suspended paper fibers and use of this method |
| 01/02/2003 | US20030000285 Method at detection of presence of hydrogen gas and measurement of content of hydrogen gas |
| 01/02/2003 | US20030000281 Automatic gas sensor calibration system |
| 01/02/2003 | EP1271351A1 Method of anticipating interaction between proteins |
| 01/02/2003 | EP1271182A2 Stimulable phosphor sheet for detection of substances originating from a living body |
| 01/02/2003 | EP1271154A2 Biological applications of semiconductor nanocrystals |
| 01/02/2003 | EP1271153A2 Collapsin response mediator protein-1 as tumor metastasis marker |
| 01/02/2003 | EP1271152A1 Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor |
| 01/02/2003 | EP1271151A1 Assay and process for the detection of HPV antibodies |
| 01/02/2003 | EP1271150A2 Test strip for use in measurement device |
| 01/02/2003 | EP1271149A2 Structure with immobilized biological material and method for manufacturing the same |
| 01/02/2003 | EP1271148A1 High-throughput screening assay systems in microscale fluidic devices |
| 01/02/2003 | EP1271147A1 Test paper |
| 01/02/2003 | EP1271145A1 Methods and cell populations for identifying and validating genomic targets, and for drug screening |
| 01/02/2003 | EP1271144A1 Method and circuitry for controlling and measuring electrical parameters in a biological membrane |
| 01/02/2003 | EP1271143A1 Specimen having capability of separating solid component |
| 01/02/2003 | EP1271142A1 Method and apparatus for determining surface smoothness of paper |
| 01/02/2003 | EP1271141A1 Apparatus and method for determining biological heat potential of a waste water treatment system. |
| 01/02/2003 | EP1271140A1 Determination of in-mouth sensory properties of foodstuffs |
| 01/02/2003 | EP1271136A1 Sensor cartridge, sensor feeder, and measuring instrument |
| 01/02/2003 | EP1271135A2 System and method for deconvoluting the effect of topography on scanning probe microscopy measurements |
| 01/02/2003 | EP1271133A1 Measuring method using long life fluorescence of excitation type |
| 01/02/2003 | EP1271125A2 Automatic smear preparing apparatus and automatic sample analysis system having the same |
| 01/02/2003 | EP1271124A1 Pretreatment instrument of saliva and pretreatment method of saliva |
| 01/02/2003 | EP1270745A2 Thymosin B15 as a marker in diagnosis and prognosis of cancer |
| 01/02/2003 | EP1270740A1 Biochip and its use for determining inflammation |
| 01/02/2003 | EP1270737A1 Preincubation assay method |
| 01/02/2003 | EP1270725A1 Anticalines |
| 01/02/2003 | EP1270596A1 Antibody/carrier complex, process for producing the same, method of controlling antigen-antibody reaction by using the same and immunoassay method |
| 01/02/2003 | EP1270595A1 Gene recombinant antibody and its fragment |
| 01/02/2003 | EP1270594A1 Antibodies to peptide from a soluble fragment of acetylcholinesterase |
| 01/02/2003 | EP1270593A2 HSCA-3 antigen and monoclonal antibody which recognizes the antigen |
| 01/02/2003 | EP1270592A1 Monoclonal antibody, mAb 1E8, which is specific for the first 2 amino-terminal amino acids of beta-amyloid peptides and its use in the detection of beta-amyloid peptides or sAPPs |
| 01/02/2003 | EP1270591A1 Transgenic cells and a method for detecting disruptors for androgens by using said transgenic cells |
| 01/02/2003 | EP1270588A1 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
| 01/02/2003 | EP1270044A2 Wound healing biomarkers |
| 01/02/2003 | EP1269508A4 Systems and methods for high performance scanning |
| 01/02/2003 | EP1269508A2 Systems and methods for high performance scanning |
| 01/02/2003 | EP1269390A2 Method to evaluate the systemic exposure in toxicological and pharmacological studies |
| 01/02/2003 | EP1269213A2 Method for the esr-spectroscopic detection of changes in the transport properties of albumin in an albumin-containing sample, esr-spectrometer for carrying out said method, and use of the method for diagnostic purposes and for controlling albumin-containing preparations |
| 01/02/2003 | EP1269201A1 Alpha 7 nicotinic receptor screening assays |
| 01/02/2003 | EP1269200A2 Method for prediction of preeclampsia and other diseases |
| 01/02/2003 | EP1269199A2 Methods involving induced dimerisation by cellular components |
| 01/02/2003 | EP1269198A2 Identification of mast/basophil activation inhibitors |
| 01/02/2003 | EP1269197A2 Detection of nerve damage using marker scip |
| 01/02/2003 | EP1269196A1 Method of screening for inhibitors of osteopontin |
| 01/02/2003 | EP1269195A2 Methods for identifying and isolating tissue-specific lumen-exposed molecules |
| 01/02/2003 | EP1269194A2 Prostate cancer markers |
| 01/02/2003 | EP1269193A2 A lysosomal pepstatin-insensitive proteinase as biomarker for breast cancer |
| 01/02/2003 | EP1269192A1 Biotin-peg-substrate for a lipase assay |
| 01/02/2003 | EP1269191A1 Docosahexaenoic acid as retinoid x receptor and uses thereof |
| 01/02/2003 | EP1269190A2 Method for detecting and/or quantifying first molecules |
| 01/02/2003 | EP1269188A2 One-dimensional arrays on optical fibers |
| 01/02/2003 | EP1269187A1 Function homology screening |
| 01/02/2003 | EP1269186A2 Immunoassays detecting or making use of at least two rubber latex allergens |
| 01/02/2003 | EP1269185A2 Methods of registering trans-membrane electric potentials |
| 01/02/2003 | EP1269183A1 Assay for agents that induce chemokinesis |
| 01/02/2003 | EP1269182A1 Capture assay utilising a particulate analyte |
| 01/02/2003 | EP1269181A2 Assay methods for hydratable cementitious compositions |